Michael Thomas Heffernan - 25 Mar 2025 Form 3 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Donald R. Reynolds, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
25 Mar 2025
Net transactions value
$0
Form type
3
Filing time
26 Mar 2025, 16:01:16 UTC
Previous filing
12 Feb 2025
Next filing
07 May 2025

No securities are beneficially owned.